Safety and efficacy of Daclatasvir and Asunaprevir combination therapy for hemodialyzed patients with chronic hepatitis C
Latest Information Update: 07 Oct 2022
At a glance
- Drugs Asunaprevir (Primary) ; Daclatasvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 06 Oct 2022 Status changed from recruiting to completed.
- 30 Jan 2015 New trial record